Healthpeak Properties, Inc.
DOC Real Estate REIT - Healthcare Facilities NYSE
$17.02
$-0.17 (-0.96%)
Open: $17.14 | High: $17.24 | Low: $17.01 | Prev Close: $17.19
Market Cap: $11.83B
Volume: 6.0M | Avg: 8.1M
Last updated: December 05, 2025 at 10:01 PMInvestment Rating
Sell
Overall Score: 40/100
Rating Breakdown:
Stock Score Analysis
Stock Score: 420
Comprehensive Quality Assessment
Component Breakdown:
Valuation Metrics
| P/E Ratio | -283.67 |
| P/B Ratio | 1.56 |
| P/S Ratio | 3.85 |
| EPS | $-0.06 |
| Beta | 1.10 |
| Shares Outstanding | 694.95M |
| 52-Week High | $21.83 |
| 52-Week Low | $16.63 |
| SMA 50 | $18.19 |
| SMA 200 | $18.25 |
| Dividend Yield | 6.57% |
| Annual Dividend | $1.12 |
| Next Earnings | February 02, 2026 05:00 AM ET |
Financial Ratios
| Gross Margin | 63.6% |
| Operating Margin | 17.8% |
| Net Margin | -1.2% |
| ROE | -0.5% |
| ROA | -0.2% |
| Debt/Equity | 1.26 |
| Current Ratio | 0.79 |
| Quick Ratio | 0.79 |
Balance Sheet
| Total Assets | $19.94B |
| Total Liabilities | $10.88B |
| Total Equity | $8.40B |
| Cash | $119.82M |
| Total Debt | $9.02B |
| Net Debt | $8.90B |
Income Statement
| Revenue | $2.70B |
| Gross Profit | $1.63B |
| Operating Income | $471.22M |
| Net Income | $243.14M |
| EBITDA | $1.61B |
| Revenue/Share | $4.41 |
Cash Flow
| Operating CF | $1.07B |
| CapEx | N/A |
| Free Cash Flow | $1.07B |
| Book Value/Share | $11.87 |
| Tangible Book/Share | $10.99 |
| Equity/Share | $10.91 |
Technical Indicators
| RSI (14) | 44.21 Neutral |
| MACD |
-0.10
Signal: -0.09
|
| Volatility | 28.53% |
| Trading Signal | Bearish |
Performance & Returns
| 1 Year | -12.72% |
| Sharpe Ratio | -0.79 Poor |
| Volatility (Ann.) | 24.3% Moderate |
| DOC (1Y) | -12.72% |
| S&P 500 (1Y) | +11.86% |
| Alpha (Excess Return) | -24.58% |
Sector Comparison (Real Estate)
| Metric | DOC | Sector Avg | Percentile |
|---|---|---|---|
| P/E Ratio | -283.67 | 75.77 | 0% |
| P/B Ratio | 1.56 | 1.76 | 23% |
| ROE (%) | -0.48% | 24.36% | 13% |
| Net Margin (%) | -1.25% | 17.49% | 10% |
| Stock Score | 420 | 471.0 | 23% |
| 1Y Return (%) | -12.72% | -7.35% | 32% |
Historical Price Analysis (Last 200 Days)
Technical Analysis
| Ticker | Close | SMA 5 | SMA 8 | SMA 13 | SMA 50 | SMA 200 | RSI (14) | MACD | Volatility (%) | Volume | Signal | SMA Decision |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| DOC | $17.02 | $17.79 | $17.89 | $17.77 | $18.19 | $18.25 | 44.21 | -0.10 | 28.53% | 7564351 | Weak Short | Price Below SMAs |
Candlestick Patterns
There wasn't any recognizable pattern for the DOC stock
News Sentiment
| 📊 Ticker | 📰 Headline | 💭 Sentiment | 📡 Source | 🔗 URL |
|---|---|---|---|---|
| DOC | Healthpeak Properties, Inc. (NYSE:DOC) Receives Consensus Rating of “Moderate Buy” from Analysts | Neutral | defenseworld.net | Read More |
| DOC | Our December High-Yield 6% Dividend Stocks Have Big Total Return Potential | Neutral | 247wallst.com | Read More |
| DOC | Healthpeak Properties: Healthcare REIT Paying Monthly Dividends, Solid Recovery Potential | Neutral | seekingalpha.com | Read More |
| DOC | Cetera Investment Advisers Sells 7,104 Shares of Healthpeak Properties, Inc. $DOC | Neutral | defenseworld.net | Read More |
| DOC | 3 Best Monthly Paying Dividend Stocks in the S&P 500 | Neutral | 247wallst.com | Read More |
Company Information
Healthpeak Properties, Inc. is a fully integrated real estate investment trust (REIT) and S&P 500 company. Healthpeak owns, operates, and develops high-quality real estate for healthcare discovery and delivery.
| CEO | Scott Brinker |
| Employees | 387 |
| Country | US |
| IPO Date | 1985-05-23 |
| Exchange | NYSE |
| Website | https://www.healthpeak.com |
| Sector | Real Estate |
| Industry | REIT - Healthcare Facilities |
Similar Stocks (Real Estate - REIT - Healthcare Facilities)
Rating Metrics Explained
DCF Score (Discounted Cash Flow)
Measures the intrinsic value of the stock based on projected future cash flows. A higher score indicates the stock is undervalued relative to its DCF valuation.
ROE Score (Return on Equity)
Evaluates how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better profitability and management effectiveness.
ROA Score (Return on Assets)
Measures how efficiently a company uses its assets to generate profit. A higher ROA means better asset utilization and operational efficiency.
D/E Score (Debt-to-Equity)
Assesses the company's financial leverage and risk. Lower debt-to-equity ratios indicate less financial risk and better balance sheet health.
P/E Score (Price-to-Earnings)
Compares stock price to earnings per share. A lower P/E ratio may indicate the stock is undervalued, while a higher ratio could suggest overvaluation or growth expectations.
P/B Score (Price-to-Book)
Compares market price to book value per share. Lower P/B ratios may indicate undervaluation relative to the company's net asset value.
Rating Recommendations:
Each metric is scored on a scale of 1-5, where the scores are determined by comparing the company's performance against industry benchmarks and historical data:
-
Strong Buy (5/5): Excellent score - strong positive indicator
- The metric significantly outperforms industry averages (top 20% of companies)
- Indicates exceptional financial health or attractive valuation in that category
-
Buy (4/5): Good score - positive indicator
- Above-average performance (top 40% of companies)
- Shows strong fundamentals with room for improvement
-
Neutral (3/5): Average score - neutral indicator
- Performance in line with industry median (middle 20%)
- Neither significantly positive nor negative signal
-
Sell (2/5): Below average - negative indicator
- Below-average performance (bottom 40% of companies)
- Suggests weakness in this particular metric
-
Strong Sell (1/5): Poor score - strong negative indicator
- Significantly underperforms industry (bottom 20%)
- Indicates potential risk or overvaluation in that category